02/17/2022 Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University Read More
10/07/2021 Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases Read More
10/07/2021 Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases Read More